L & S Advisors Inc Abbott Laboratories Transaction History

L & S Advisors Inc

$832 Million
Q3 2024

A detailed history of L & S Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, L & S Advisors Inc holds 18,151 shares of ABT stock, worth $2.14 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

18,151

Previous 18,070 0.45%

Holding current value

$2.14 Million

Previous $1.88 Million 10.23%

% of portfolio

0.25%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$100.07 - $118.13 $8,105 - $9,568	81 Added 0.45%	18,151 $2.07 Million
Q2 2024 Aug 09, 2024	SELL	$100.73 - $112.44 $6.76 Million - $7.54 Million	-67,091 Reduced 78.78%	18,070 $1.88 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $7.35 Million - $8.12 Million	67,091 Added 371.28%	85,161 $9.68 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $5,230 - $6,156	-54 Reduced 0.3%	18,070 $1.83 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $12,357 - $14,497	-130 Reduced 0.71%	18,124 $1.99 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $5,418 - $6,273	-56 Reduced 0.31%	18,254 $1.77 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $48,483 - $58,600	-475 Reduced 2.53%	18,310 $1.99 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $6.33 Million - $7.71 Million	-55,484 Reduced 74.71%	18,785 $2.22 Million
Q4 2021 Feb 09, 2022	BUY	$115.53 - $141.46 $6.3 Million - $7.71 Million	54,496 Added 275.61%	74,269 $10.5 Million
Q3 2021 Nov 09, 2021	SELL	$116.66 - $129.06 $13,415 - $14,841	-115 Reduced 0.58%	19,773 $2.34 Million
Q2 2021 Aug 12, 2021	SELL	$105.79 - $124.53 $2.17 Million - $2.55 Million	-20,470 Reduced 50.72%	19,888 $2.31 Million
Q1 2021 May 10, 2021	SELL	$108.84 - $128.23 $12,843 - $15,131	-118 Reduced 0.29%	40,358 $4.84 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $193,830 - $211,219	1,846 Added 4.78%	40,476 $4.43 Million
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $174,299 - $211,673	1,902 Added 5.18%	38,630 $4.2 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $371,211 - $475,104	-4,848 Reduced 11.66%	36,728 $3.36 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $37,252 - $54,472	593 Added 1.45%	41,576 $3.28 Million
Q4 2019 Feb 13, 2020	BUY	$78.51 - $87.4 $101,827 - $113,357	1,297 Added 3.27%	40,983 $3.56 Million
Q3 2019 Nov 14, 2019	BUY	$81.84 - $88.74 $31,672 - $34,342	387 Added 0.98%	39,686 $3.32 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $1.31 Million - $1.53 Million	17,951 Added 84.09%	39,299 $3.31 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $5,959 - $7,205	-90 Reduced 0.42%	21,348 $1.71 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $5,900 - $6,684	90 Added 0.42%	21,438 $1.55 Million
Q2 2017 Aug 14, 2017	BUY	N/A	21,348	21,348 $1.04 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account